In this Supplement
How to incorporate drug-coated balloons and drug-eluting stents into your practice.
What the data tell us about how to integrate drug-eluting technology into our daily practice.
By Gary Ansel, MD, and John A. Phillips, MD
The history, data, and latest advancements in stenting of the SFA and popliteal arteries.
By John R. Laird, MD, and Ehrin J. Armstrong, MD
How I integrate this versatile tool into my lower extremity practice.
By William A. Gray, MD
The use of drug-coated balloons is creating a paradigm shift in the treatment of peripheral arterial disease by preventing restenosis and leaving nothing behind.
By George L. Adams, MD, MHS, and O Jesse Mendes, BA
As devices develop and longer follow-up data become available, one thing is certain: It’s a drug-eluting world, all right.
By Konstantinos Katsanos, MSc, MD, PhD, EBIR
Looking beyond prices and assessing the true value of new technologies.
By Louis L. Nguyen, MD, MBA, MPH, and Rebecca E. Scully, MD
Should the current data on drug-eluting devices cause surgeons to reconsider when to use bypass?